HOME PAGE

MoCAŠ News:

MoCAŠ Creator and Copyright Owner:
    Dr Ziad S. Nasreddine MD FRCP (C)
    McGill University, and Sherbrooke University Canada

MoCAŠ Development Team Collaborators:
    Dr Howard Chertkow MD FRCP (C)
    McGill University Canada

    Dr Natalie Phillips PhD
    Concordia University Canada

Collaborators who provide valuable input and advice:
    Dr Valérie Bédirian PhD
    University of Montreal Canada

    Dr Jeffrey L. Cummings MD
    Cleveland Clinic, Las Vegas USA

    Dr Glen R. Finney MD
    University of Florida USA

    Dr Serge Gauthier MD FRCP (C)
    McGill University Canada


MoCA News Update April 2, 2013

New milestones for the MoCA!

The MoCA test is now used in 100 countries*, in almost every letter of the alphabet, and translated to 36 languages and dialects.
It is currently used for detection of Mild Cognitive Impairment in multiple conditions:
MCI/Alzheimer's disease, Vascular Cognitive Impairment, Parkinson, HIV, Fronto-temporal dementia, Huntington, Multiple Sclerosis, Heart failure, Lung disease, REM sleep disorders, Sleep apnea, Substance abuse, Visual impairment, Brain tumors, Lupus, Epilepsy.

It has been validated in 21 languages/dialects. It is also available in parallel versions in English, and German. See References' section for more information at www.mocatest.org .

The MoCA Validation Study article published in JAGS in 2005 has been cited by 1269 articles in peer reviewed journals.

Upcoming developments:

MoCA-MIS: To assess the usefulness of the Montreal Cognitive Assessment Memory Index Score, MoCA-MIS, As a Predictor of Mild Cognitive Impairment Conversion to Alzheimer's Disease. Abstract presented at AAIC Conference, Vancouver 2012
MoCA-ACE: To obtain normative data for Age (18-99 years), Culture (10 languages), and Education (3-15 and more years)
MoCA-Drive: To assess MoCA's ability to predict success or failure on a road test
MoCA-Alternate versions: To develop parallel versions of the test to decrease possible learning effects when the test is frequently administered
MoCA-Basic: To develop a MoCA version for illiterate and less educated subjects
Mini-MoCA: To develop a short 5 minute version of the MoCA
MoCA-ADL: To correlate cognition domains on the MoCA with everyday function
MoCA-App: For Tablet/Smart Phones users
MoCA-Certification: An online program to help improve standardized administration and interpretation

Thank you all for your interest in the MoCA test, and thanks to all the collaborators!
Do not hesitate to send us your MoCA comments and questions to info@mocatest.org

Dr Ziad Nasreddine MD FRCP(C) Neurologist
On behalf of the MoCAŠ Team
www.mocatest.org

*Based on MoCA Data Base of registered users that requested updates on the test.


November 2010

MoCAŠ ACE Study:
    Montreal Cognitive Assessment (MoCAŠ) Normative Data for Age, Culture and Education.
    Variables:
        This study aims to provide freely accessible normative data for the MoCAŠ across ages, education
        levels, in 10 languages and cultures.
        Well-validated, reliable, freely accessible normative data for the MoCAŠ will be an invaluable aid
        to help clinicians around the world detect and diagnose early and efficiently various causes of
        cognitive impairment across various ages and education levels. The normative data will also help
        researchers assess various cognitive therapies and outcome predictors, and will allow international
        collaboration when using a common well-validated and normed cognitive screening tool. Through
        this study, official, comparable, well-normed versions of the MoCAŠ will be made available in 10
        languages/dialects.
        This study is in the planning stage. Interested investigators are invited to contact Dr Ziad Nasreddine
        for more information at info@mocatest.org

ADNI 2 to include testing with the MoCAŠ:
    The Alzheimer's Disease Neuroimaging Initiative (ADNI) is currently into its extension (ADNI-Go) and
    will be starting its second phase (ADNI 2) next year. The MoCAŠ will be administered as part of
    ADNI 2, with data gathered on a large set of early and late MCI individuals, normals, and AD
    research subjects. This will provide a large dataset for future research.

MoCAŠ Alternate Versions:
    To decrease possible learning effects when the MoCA is administered repetitively, four alternative
    MoCAŠ forms are in development. Two versions in English (validation study completed) will be
    shortly posted on the MoCAŠ website, and two French alternate versions are undergoing validation.
    Phillips N. et al. Validation of alternate forms for the Montreal Cognitive Assessment (MoCAŠ) will
    be presented at the 39th International Neuropsychological Society Meeting in Boston February 2-5,
    2011.

MoCAŠ in Low Education:
    To better adjust the MoCA for lower educated subjects, 2 points should be added to the total
    MoCAŠ score for subjects with 4-9 years of education, 1 point for 10-12 years of education.
    Johns E.K. et al. Level of education and performance on the Montreal Cognitive Assessment
    (MoCAŠ): New recommendations for education corrections. Presented at the Cognitive Aging
    Conference 2010, Atlanta, Georgia, April 15-18th, 2010.
    Johns E.K. et al. The Montreal Cognitive Assessment (MoCAŠ): Normative Data in the Community.
    The Canadian Journal of Geriatrics 2008, 11 (1), 62. Abstract.

MoCAŠ for the Blind:
    A version of the MoCAŠ without the visual elements has been validated for the blind.
    Wittich W et al. Sensitivity and specificity of the Montreal Cognitive Assessment modified for
    individuals who are visually impaired. Journal of Visual Impairment & Blindness, 104(6), 360-368,
    June 2010.

MoCAŠ is recommended by NIH and Canadian Stroke Consortium for Cognitive Assessment after
Stroke.

Because it contains subtests with executive function as well as memory, the MoCAŠ is ideal for
assessing Vascular Dementia and Vascular Cognitive Impairment (VCI) which may have significant frontal
lobe pathology. A workshop group of NIH and Canadian Stroke Consortium has suggested a brief
method of assessment of cognition in VCI/Vascular Dementia, which largely relies on components of the
MoCAŠ.
Hachinski et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network
vascular cognitive impairment harmonization standards. Stroke 2006, Sep;37(9):2220-41.

Return to HOME PAGE

CopyrightŠ Dr Z. Nasreddine 2003 to 2014 - The Montreal Cognitive Assessment - MoCAŠ - All rights reserved